Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patients.
<h4>Background</h4>To compare the effect of aprotinin with the effect of lysine analogues (tranexamic acid and ε-aminocaproic acid) on early mortality in three subgroups of patients: low, intermediate and high risk of cardiac surgery.<h4>Methods and findings</h4>We performed...
Guardado en:
Autores principales: | Patrick Meybohm, Eva Herrmann, Julia Nierhoff, Kai Zacharowski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1e29d4fe4e54ee89eea77d10db35d23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tranexamic Acid versus Epsilon-Aminocaproic Acid in Total Knee Arthroplasty: A Meta-Analysis
por: Zhihui Li, et al.
Publicado: (2021) -
Metabolic factors and the risk of Dupuytren’s disease: data from 30,000 individuals followed for over 20 years
por: Mattias Rydberg, et al.
Publicado: (2021) -
KINETICS AND MECHANISM OF OXIDATION OF 6-AMINOCAPROIC ACID BY DIHYDROXYDIPERIODATOA RGENTATE (III) IN ALKALINE MEDIUM
por: HUO,SHUYING, et al.
Publicado: (2007) -
Tranexamic acid in otorhinolaryngology – A contemporary review
por: Jordan Fuzi, et al.
Publicado: (2021) -
A systematic review of tranexamic acid usage in patients undergoing femoral fracture surgery
por: Zhang P, et al.
Publicado: (2018)